5SFA

Crystal Structure of human phosphodiesterase 10 in complex with 6-cyclopropyl-3-[(1-methyl-4-phenylimidazol-2-yl)methoxy]-N-(oxolan-3-yl)pyrazine-2-carboxamide

Experimental procedure

Experimental method	SINGLE WAVELENGTH
Source type	SYNCHROTRON
Source details	SLS BEAMLINE X10SA
Synchrotron site	SLS
Beamline	X10SA
Temperature [K]	100
Detector technology	PIXEL
Collection date	2011-05-03
Detector	PSI PILATUS 6M
Wavelength(s)	0.999900
Spacegroup name	H 3
Unit cell lengths	134.748, 134.748, 234.145
Unit cell angles	90.00, 90.00, 120.00

Refinement procedure

Resolution	43.340 - 2.320
R-factor	0.1778
Rwork	0.175
R-free	0.22690
Structure solution method	MOLECULAR REPLACEMENT
Starting model (for MR)	inhouse model
RMSD bond length	0.007
RMSD bond angle	1.496
Data reduction software	XDS
Data scaling software	XSCALE
Phasing software	PHASER
Refinement software	REFMAC (5.8.0258)

Data quality characteristics

	Overall	Inner shell	Outer shell
Low resolution limit [Å]	43.340	43.340	2.380
High resolution limit [Å]	2.320	10.380	2.320
Rmerge	0.088	0.027	1.128
Rmeas	0.098	0.031	1.260
Total number of observations	352902
Number of reflections	68524	756	5080
<I/σ(I)>	10.18	42.12	1.38
Completeness [%]	99.8	98.7	99.8
Redundancy	5.16	5.061	5.041
CC(1/2)	0.998	0.999	0.569

Crystallization Conditions

crystal ID	method	pH	temperature	details
1	VAPOR DIFFUSION, SITTING DROP	7.5	295	5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2